Evidence map›Paper›PMID 16379003›Full record

ArticleJournal of virology2006

Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.

Chantelle Hood, Anthony L Cunningham, Barry Slobedman, Ann M Arvin, Marvin H Sommer, Paul R Kinchington, Allison Abendroth

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Varicella Zoster Virus Neuronal Latency and Reactivation Modeled in Vitro.Current topics in microbiology and immunology · 2023
    Review
  6. Modulation of Apoptosis and Cell Death Pathways by Varicella-Zoster Virus.Current topics in microbiology and immunology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Herpesviral Latency-Common Themes.Pathogens (Basel, Switzerland) · 2020
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Herpes zoster and the search for an effective vaccine.Clinical and experimental immunology · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Chantelle HoodCentre for Virus Research, Westmead Millennium Institute, and University of Sydney, P.O. Box 412, Westmead, 2145 NSW, Australia.
Anthony L Cunningham
Barry Slobedman
Ann M Arvin
Marvin H Sommer
Paul R Kinchington
Allison Abendroth
Millennium Institute · BRStanford University · USUniversity of Pittsburgh · USUniversity of Sydney · AU

Funding

Virus Production and Manipulation of Protein/Gene Expression ModuleP30EY008098 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ethan A Rossi · 1989 to 2026
$17.8M
VARICELLA ZOSTER VIRUS REGULATORY PROTEINSR01EY009397 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KINCHINGTON, PAUL R. · 1992 to 2005
$2.2M
NEI NIH HHS EY09397NEI NIH HHS EY8098NEI NIH HHS P30 EY008098NEI NIH HHS R01 EY009397
6 · The paper itself

Abstract

Virus-encoded modulation of apoptosis may serve as a mechanism to enhance cell survival and virus persistence. The impact of productive varicella-zoster virus (VZV) infection on apoptosis appears to be cell type specific, as infected human sensory neurons are resistant to apoptosis, yet human fibroblasts readily become apoptotic. We sought to identify the viral gene product(s) responsible for this antiapoptotic phenotype in primary human sensory neurons. Treatment with phosphonoacetic acid to inhibit viral DNA replication and late-phase gene expression did not alter the antiapoptotic phenotype, implicating immediate-early (IE) or early genes or a virion component. Compared to the parental VZV strain (rOKA), a recombinant virus unable to express one copy of the diploid IE gene ORF63 (rOka deltaORF63) demonstrated a significant induction of apoptosis in infected neurons, as determined by three methods: annexin V staining, deoxynucleotidyltransferase-mediated dUTP-biotin nick end label staining, and transmission electron microscopy. Furthermore, neurons transfected with a plasmid expressing ORF63 resisted apoptosis induced by nerve growth factor withdrawal. These results show that ORF63 can suppress apoptosis of neurons and provide the first identification of a VZV gene encoding an antiapoptotic function. As ORF63 is expressed in neurons during both productive and latent infection, it may play a significant role in viral pathogenesis by promoting neuron survival during primary and reactivated infections.

Indexed as

ApoptosisCells, CulturedChickenpoxDown-RegulationHerpesvirus 3, HumanHumansImmediate-Early ProteinsNeurons, AfferentViral Envelope Proteinsimmediate early protein 63, Human herpesvirus 3Immediate-Early ProteinsViral Envelope Proteins

Identifiers

PMID16379003
PMCPMC1346839
OpenAlexW2017036054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.